Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Ryan B Ko"'
Autor:
Saud Alhusaini, Tyler A. Lanman, Ryan B. Ko, Kate E. Therkelsen, Rie Von Eyben, Maximilian Diehn, Scott G. Soltys, Erqi L. Pollom, Alexander Chin, Lucas Vitzthum, Heather A. Wakelee, Sukhmani K. Padda, Kavitha Ramchandran, Billy W. Loo, Joel W. Neal, Seema Nagpal
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
ObjectiveThe 2-year incidence of brain metastases (BrMs) in stage III non-small lung cell cancer (NSCLC) has been estimated to be around 30%. However, recent clinical trials have demonstrated considerably lower BrMs rates in this patient population.
Externí odkaz:
https://doaj.org/article/1602470f0af344dd9205ca40704d4461
Autor:
Maximilian Diehn, Billy W. Loo, Ash A. Alizadeh, Heather A. Wakelee, Joel W. Neal, Millie Das, Sukhmani K. Padda, Kavitha J. Ramchandran, Joseph B. Shrager, Mark F. Berry, Leah M. Backhus, Natalie S. Lui, Peter G. Maxim, June Ho Shin, Ryan B. Ko, Susie Grant Owen, Linda Gojenola, David M. Kurtz, Emily Hamilton, Jacob J. Chabon, Michael Xiang, Siyeon Rhee, Christopher H. Yoo, Henning Stehr, Christian Kunder, Diego Almanza, Barzin Y. Nabet, Everett J. Moding, Monica Nesselbush, Young-Jun Jeon, Michael S. Binkley
Tumor genotyping is not routinely performed in localized non–small cell lung cancer (NSCLC) due to lack of associations of mutations with outcome. Here, we analyze 232 consecutive patients with localized NSCLC and demonstrate that KEAP1 and NFE2L2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f5a84f186e7ebd2223ca38e94d27cf1
https://doi.org/10.1158/2159-8290.c.6547724.v1
https://doi.org/10.1158/2159-8290.c.6547724.v1
Autor:
Maximilian Diehn, Billy W. Loo, Ash A. Alizadeh, Heather A. Wakelee, Joel W. Neal, Millie Das, Sukhmani K. Padda, Kavitha J. Ramchandran, Joseph B. Shrager, Mark F. Berry, Leah M. Backhus, Natalie S. Lui, Peter G. Maxim, June Ho Shin, Ryan B. Ko, Susie Grant Owen, Linda Gojenola, David M. Kurtz, Emily Hamilton, Jacob J. Chabon, Michael Xiang, Siyeon Rhee, Christopher H. Yoo, Henning Stehr, Christian Kunder, Diego Almanza, Barzin Y. Nabet, Everett J. Moding, Monica Nesselbush, Young-Jun Jeon, Michael S. Binkley
Table S1 - S7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d326f134a0c185c8ffe24a68be4466b
https://doi.org/10.1158/2159-8290.22534982.v1
https://doi.org/10.1158/2159-8290.22534982.v1
Autor:
Maximilian Diehn, Billy W. Loo, Ash A. Alizadeh, Heather A. Wakelee, Joel W. Neal, Millie Das, Sukhmani K. Padda, Kavitha J. Ramchandran, Joseph B. Shrager, Mark F. Berry, Leah M. Backhus, Natalie S. Lui, Peter G. Maxim, June Ho Shin, Ryan B. Ko, Susie Grant Owen, Linda Gojenola, David M. Kurtz, Emily Hamilton, Jacob J. Chabon, Michael Xiang, Siyeon Rhee, Christopher H. Yoo, Henning Stehr, Christian Kunder, Diego Almanza, Barzin Y. Nabet, Everett J. Moding, Monica Nesselbush, Young-Jun Jeon, Michael S. Binkley
Supplementary Figures 1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::013b147cf3cd85390bdd0a71b02d8d49
https://doi.org/10.1158/2159-8290.22534988.v1
https://doi.org/10.1158/2159-8290.22534988.v1
Autor:
Maximilian Diehn, Ash A. Alizadeh, Bob T. Li, Taha Merghoub, Charles M. Rudin, Mark G. Kris, Jamie E. Chaft, Joel W. Neal, Sukhmani K. Padda, Heather A. Wakelee, Linda Gojenola, Henning Stehr, Ryan B. Ko, Christopher H. Yoo, Rocio Perez Johnston, Andrew J. Plodkowski, Mohsen Abu-Akeel, Megan Tenet, Hyejin Choi, Jennifer L. Sauter, Rene F. Bonilla, Diego Almanza, Everett J. Moding, Isabel R. Preeshagul, Jia Luo, Kathryn C. Arbour, Angela B. Hui, Chih Long Liu, Jacob J. Chabon, Mark P.S. Dunphy, Daniel K. Wells, Aadel A. Chaudhuri, Hira Rizvi, Barzin Y. Nabet, Matthew D. Hellmann
Supplementary Figures related to Figures 1, 2, 3, and 4.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f489ee1701cc6463d9f7a67bef53ce5
https://doi.org/10.1158/1078-0432.22478318
https://doi.org/10.1158/1078-0432.22478318
Autor:
Maximilian Diehn, Ash A. Alizadeh, Bob T. Li, Taha Merghoub, Charles M. Rudin, Mark G. Kris, Jamie E. Chaft, Joel W. Neal, Sukhmani K. Padda, Heather A. Wakelee, Linda Gojenola, Henning Stehr, Ryan B. Ko, Christopher H. Yoo, Rocio Perez Johnston, Andrew J. Plodkowski, Mohsen Abu-Akeel, Megan Tenet, Hyejin Choi, Jennifer L. Sauter, Rene F. Bonilla, Diego Almanza, Everett J. Moding, Isabel R. Preeshagul, Jia Luo, Kathryn C. Arbour, Angela B. Hui, Chih Long Liu, Jacob J. Chabon, Mark P.S. Dunphy, Daniel K. Wells, Aadel A. Chaudhuri, Hira Rizvi, Barzin Y. Nabet, Matthew D. Hellmann
Table S2: Surveillance plasma sample ctDNA metrics. Table S3: Baseline plasma sample ctDNA metrics. Table S4: Surveillance plasma sample variants in ctDNA detected samples. Table S5: Baseline plasma variants in available samples. Table S6: Tumor vari
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::341d85fe151e74fa4e8ab0c7d7b5dc07
https://doi.org/10.1158/1078-0432.22478312
https://doi.org/10.1158/1078-0432.22478312
Autor:
Maximilian Diehn, Ash A. Alizadeh, Bob T. Li, Taha Merghoub, Charles M. Rudin, Mark G. Kris, Jamie E. Chaft, Joel W. Neal, Sukhmani K. Padda, Heather A. Wakelee, Linda Gojenola, Henning Stehr, Ryan B. Ko, Christopher H. Yoo, Rocio Perez Johnston, Andrew J. Plodkowski, Mohsen Abu-Akeel, Megan Tenet, Hyejin Choi, Jennifer L. Sauter, Rene F. Bonilla, Diego Almanza, Everett J. Moding, Isabel R. Preeshagul, Jia Luo, Kathryn C. Arbour, Angela B. Hui, Chih Long Liu, Jacob J. Chabon, Mark P.S. Dunphy, Daniel K. Wells, Aadel A. Chaudhuri, Hira Rizvi, Barzin Y. Nabet, Matthew D. Hellmann
Table S1 shows summary patient demographics, pathologic features, and treatment details
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f17d6472b1ce8901ff174b6e6d0b73f
https://doi.org/10.1158/1078-0432.22478309.v1
https://doi.org/10.1158/1078-0432.22478309.v1
Autor:
Maximilian Diehn, Ash A. Alizadeh, Bob T. Li, Taha Merghoub, Charles M. Rudin, Mark G. Kris, Jamie E. Chaft, Joel W. Neal, Sukhmani K. Padda, Heather A. Wakelee, Linda Gojenola, Henning Stehr, Ryan B. Ko, Christopher H. Yoo, Rocio Perez Johnston, Andrew J. Plodkowski, Mohsen Abu-Akeel, Megan Tenet, Hyejin Choi, Jennifer L. Sauter, Rene F. Bonilla, Diego Almanza, Everett J. Moding, Isabel R. Preeshagul, Jia Luo, Kathryn C. Arbour, Angela B. Hui, Chih Long Liu, Jacob J. Chabon, Mark P.S. Dunphy, Daniel K. Wells, Aadel A. Chaudhuri, Hira Rizvi, Barzin Y. Nabet, Matthew D. Hellmann
Purpose:Treatment with PD-(L)1 blockade can produce remarkably durable responses in patients with non–small cell lung cancer (NSCLC). However, a significant fraction of long-term responders ultimately progress and predictors of late progression are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2873901c58531fb1fbb0882d5fd0489
https://doi.org/10.1158/1078-0432.c.6529919
https://doi.org/10.1158/1078-0432.c.6529919
Autor:
Max Devine, David J. Merriott, Hyunsoo J. No, Brianna Lau, Carmen Say, Christopher Yoo, Esther Yi, Ryan B. Ko, Joel W. Neal, Heather A. Wakelee, Millie Das, Billy W. Loo, Maximilian Diehn, Alex L. Chin, Lucas K. Vitzthum
Publikováno v:
Practical radiation oncology. 13(1)
Stereotactic ablative radiation therapy (SABR) results in high rates of primary tumor control for early-stage non-small cell lung cancer (NSCLC). For patients with isolated hilar or mediastinal nodal recurrence (INR) after SABR, the optimal salvage t